- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vijaya Diagnostic's board has met, approving the financial results for the quarter ended June 30, 2025. Consolidated revenue reached ₹188.05 Cr, with a profit of ₹38.34 Cr and EPS of ₹3.76.
The board also approved granting 2,500 Employee Stock Options (ESOPs) under the VDCL Employee Stock Option Plan 2018, with an exercise price of ₹780 per option. These options will vest over time.
Additionally, M/s. Balaramakrishna & Associates were appointed as Secretarial Auditors for a five-year term, starting FY2025-26. This signals ongoing governance focus.